{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":655,"total_is_capped":false,"direct_labels_cover":3,"predictions_cover":655,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"9135368537ec","filters":{"venue":"Multiple Sclerosis Journal"}},"results":[{"id":"W3099273656","doi":"10.1177/1352458520970841","title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2525,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Biogen; Novartis; Multiple Sclerosis Society; Roche; Medical Research Council; Associazione Italiana Sclerosi Multipla; Sanofi; Merck; Bristol-Myers Squibb; University of Tasmania; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Epidemiology; Incidence (geometry); Compendium; Environmental health; Population; Demography; Gerontology; Geography; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1256524917755574,"gpt":0.2900817352026255,"spread":0.1644292434270681,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007875158,0.0005045192,0.001138461,0.0002314011,0.0006575694,0.0001158348,0.0008521554,0.0002147529,0.0004170454],"category_scores_gemma":[0.007283611,0.0003494418,0.0006712191,0.0009701706,0.0007743884,0.0005493232,0.0004806652,0.001358174,0.00005822826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001879889,"about_ca_system_score_gemma":0.0002443551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005828926,"about_ca_topic_score_gemma":0.0001715649,"domain_scores_codex":[0.9942762,0.0005690844,0.001676242,0.0006664555,0.002105197,0.0007068192],"domain_scores_gemma":[0.9937534,0.002603083,0.001085618,0.0007464428,0.001167148,0.0006443209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001134278,0.0004191312,0.3097609,0.0003885635,0.0005302308,0.000008032755,0.004515795,0.000293469,0.6604061,0.000008780836,0.01354218,0.008992541],"study_design_scores_gemma":[0.005628736,0.0004601819,0.8163942,0.002843515,0.0002957348,0.000008791696,0.0009101983,0.005885793,0.1661421,0.00003549689,0.001109481,0.0002857193],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864407,0.004659822,0.001607917,0.005000722,0.0005162474,0.001036751,0.0003999193,0.00008636324,0.0002515306],"genre_scores_gemma":[0.9844695,0.00806657,0.005031165,0.0005601616,0.001683213,0.00004054983,0.00003462763,0.00007451793,0.00003964971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5066333,"threshold_uncertainty_score":0.9998958,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025358672","doi":"10.1177/1352458513484547","title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Multiple sclerosis; Medicine; Acute disseminated encephalomyelitis; Neuromyelitis optica; Demyelinating Disorder; Pediatrics; Clinically isolated syndrome; Encephalomyelitis; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.122814336372852,"gpt":0.3067056860104898,"spread":0.1838913496376378,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.002996704,0.001126539,0.001514417,0.001368168,0.003757594,0.001421659,0.001333973,0.0003620776,0.0004386463],"category_scores_gemma":[0.01358694,0.0008711377,0.0008758031,0.001715256,0.0002672878,0.001135143,0.001157028,0.001605287,0.0002575119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008357102,"about_ca_system_score_gemma":0.0002160066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001189604,"about_ca_topic_score_gemma":0.0005411443,"domain_scores_codex":[0.9903257,0.0008915942,0.002714064,0.00149497,0.0021476,0.002425997],"domain_scores_gemma":[0.989369,0.004926842,0.001008818,0.001103117,0.001927519,0.001664689],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008114454,0.002918075,0.9167821,0.0005197688,0.0008404903,0.00001065444,0.003721733,0.0003968654,0.01978664,0.00001368806,0.02087918,0.03331934],"study_design_scores_gemma":[0.01370278,0.001109155,0.9467852,0.0007592841,0.0006871726,0.00005068872,0.009051209,0.02604838,0.00008748233,0.00001159829,0.0008414194,0.0008656873],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9731572,0.002621015,0.004901935,0.005495604,0.002748262,0.009495419,0.001014105,0.0004096259,0.0001568194],"genre_scores_gemma":[0.9669122,0.01172019,0.01311692,0.0003843094,0.004452306,0.002910581,0.0002057944,0.0002498299,0.00004782487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03245366,"threshold_uncertainty_score":0.999615,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135440918","doi":"10.1177/1352458508096878","title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":643,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"Multiple Sclerosis Society","keywords":"Multiple sclerosis; Differential diagnosis; Medical diagnosis; Medicine; Demyelinating Disorder; McDonald criteria; Neurology; Intensive care medicine; Pathology; Pediatrics; Immunology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.1716670000508236,"gpt":0.2906815693544226,"spread":0.119014569303599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006759436,0.0007902399,0.001819183,0.0008791691,0.001255091,0.0001073908,0.00064085,0.0003702938,0.0007602058],"category_scores_gemma":[0.004764867,0.000658446,0.001061713,0.001089046,0.001402123,0.0002366159,0.0004326563,0.001576985,0.00006788594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004201653,"about_ca_system_score_gemma":0.0004162467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004262808,"about_ca_topic_score_gemma":0.00006770514,"domain_scores_codex":[0.9929104,0.000518586,0.00183262,0.0009206472,0.002286004,0.001531676],"domain_scores_gemma":[0.9942213,0.001332595,0.0008064487,0.0009802849,0.001522259,0.00113714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001687155,0.002976731,0.7636421,0.0002125819,0.001020437,0.00008273592,0.001593929,0.0001205176,0.2096657,0.000009076106,0.01152326,0.007465807],"study_design_scores_gemma":[0.01674309,0.0006830209,0.9159927,0.0008841623,0.0002561842,0.0006868229,0.0008596646,0.00524272,0.05755727,0.000008086802,0.0004969883,0.0005892462],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937423,0.001691833,0.0007458919,0.0007136002,0.0005229734,0.001372318,0.0001893674,0.0002163052,0.0008054281],"genre_scores_gemma":[0.9781156,0.008786117,0.01141498,0.000128178,0.0008898636,0.0002773955,0.00005417736,0.0001480709,0.0001856242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1523506,"threshold_uncertainty_score":0.9995867,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105913548","doi":"10.1177/1352458514564487","title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":510,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"EMD Serono; National Institutes of Health; Multiple Sclerosis Society of Canada; Genentech; Multiple Sclerosis Society; Cleveland Clinic; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; National Heart, Lung, and Blood Institute; Pfizer; U.S. Department of Defense; Sanofi; MedDay Pharmaceuticals; GlaxoSmithKline; National Multiple Sclerosis Society; Biogen; Gilead Sciences","keywords":"Multiple sclerosis; Psychiatry; Incidence (geometry); Medicine; Systematic review; MEDLINE","retraction":null,"screen_n_in":null,"score":{"opus":0.1613057292753693,"gpt":0.3606431746107744,"spread":0.1993374453354051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008898335,0.001091613,0.006300546,0.0008406144,0.0006736568,0.0002026312,0.001383779,0.0004106814,0.00002425892],"category_scores_gemma":[0.01878738,0.0006430908,0.001295666,0.001892819,0.0008214877,0.0003483557,0.0007129799,0.002394856,0.00003958633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007018813,"about_ca_system_score_gemma":0.001074884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001051637,"about_ca_topic_score_gemma":0.0004161117,"domain_scores_codex":[0.9887816,0.002394791,0.004292758,0.0009395339,0.002377161,0.001214139],"domain_scores_gemma":[0.9902083,0.003738092,0.002887376,0.001515933,0.0008917666,0.0007585734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00006263069,0.0002469639,0.004533488,0.788922,0.0004580577,0.000005054279,0.0001596414,0.000001307731,0.000006108775,0.000002126961,0.001175752,0.2044269],"study_design_scores_gemma":[0.00261258,0.0003595166,0.01004748,0.9628882,0.004156926,0.0002649332,0.0001896483,0.0001750251,8.847919e-7,0.00001505954,0.01867071,0.0006190461],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002002262,0.9901538,0.00002134351,0.0003790303,0.0003777209,0.008648003,0.0001094944,0.00004391439,0.00006641477],"genre_scores_gemma":[0.002685132,0.9946688,0.0007450058,0.00007117782,0.0002081034,0.001345742,0.00001090804,0.0001406559,0.0001244296],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2038079,"threshold_uncertainty_score":0.9999067,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2169459006","doi":"10.1177/1352458506070928","title":"Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Myelin; Luxol fast blue stain; Multiple sclerosis; Pathology; Relaxometry; Magnetic resonance imaging; Histopathology; Remyelination; Nuclear magnetic resonance; Chemistry; Medicine; Nuclear medicine; Central nervous system; Radiology; Physics; Internal medicine; Immunology; Spin echo","retraction":null,"screen_n_in":null,"score":{"opus":0.1417452837391413,"gpt":0.3052127361807104,"spread":0.1634674524415691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002978929,0.000242738,0.0003442826,0.0003561443,0.0003951694,0.00005870511,0.0001496978,0.00006727625,0.00005439209],"category_scores_gemma":[0.0001114268,0.0001783021,0.0001143663,0.0002838091,0.0002312281,0.0002830934,0.00005386193,0.0006727495,0.00004503584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002241543,"about_ca_system_score_gemma":0.00005405874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001658429,"about_ca_topic_score_gemma":0.0001554656,"domain_scores_codex":[0.9981952,0.00008400201,0.0005713439,0.0003884581,0.0002585634,0.0005024024],"domain_scores_gemma":[0.9989839,0.0001562009,0.000183842,0.0003202275,0.0002216376,0.0001341975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002579684,0.0004437157,0.6571402,0.00001072723,0.000007352453,0.00008777779,0.0003267005,0.002156828,0.3346138,0.0002649521,0.001288843,0.003401099],"study_design_scores_gemma":[0.00474372,0.0001925952,0.9599223,0.0004879548,0.00006908626,0.0007550452,0.0002667752,0.01402611,0.01515733,0.0008253447,0.003222093,0.0003316879],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8704205,0.0003859376,0.1235191,0.004350922,0.0001221551,0.0005543021,0.00002212275,0.0002089149,0.0004161159],"genre_scores_gemma":[0.9147881,0.0001036755,0.08422899,0.0003966141,0.0001337709,0.0000944911,0.0000413483,0.0000564781,0.0001565389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3194565,"threshold_uncertainty_score":0.727095,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114728329","doi":"10.1177/1352458509347150","title":"Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Anxiety; Hospital Anxiety and Depression Scale; Depression (economics); Multiple sclerosis; Receiver operating characteristic; Confounding; Rating scale; Population; Psychiatry; Psychology; Expanded Disability Status Scale; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05894340111054678,"gpt":0.2692807458743455,"spread":0.2103373447637987,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005199477,0.0003435324,0.0005580263,0.0001753565,0.0007889125,0.0001722868,0.0002591783,0.0001478596,0.00001382331],"category_scores_gemma":[0.002110276,0.0002073813,0.0002912069,0.0003647905,0.0002804706,0.000617028,0.0001459693,0.0004634687,0.000001594408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001497081,"about_ca_system_score_gemma":0.00008263681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005153696,"about_ca_topic_score_gemma":0.00003143384,"domain_scores_codex":[0.9971108,0.0001453262,0.0006378737,0.0004679846,0.001047224,0.0005907699],"domain_scores_gemma":[0.9970009,0.0004195434,0.000484271,0.0004900487,0.001254145,0.0003510896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009458776,0.0007326925,0.8824125,0.0000487469,0.00008582768,3.431098e-7,0.0006589614,0.00007238752,0.0711785,4.559836e-7,0.001308635,0.0425551],"study_design_scores_gemma":[0.01087901,0.0008685048,0.9019958,0.001039039,0.0001322266,0.00001099951,0.0002300022,0.001755096,0.08268695,0.000007670414,0.0001710824,0.0002236218],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99607,0.0001523886,0.0009399992,0.0006476984,0.000235593,0.001769485,0.0001212798,0.00003838956,0.00002521847],"genre_scores_gemma":[0.9868783,0.0009163315,0.01165885,0.0001616185,0.0002222194,0.00005980228,0.00002488077,0.00004437107,0.00003367413],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04233148,"threshold_uncertainty_score":0.8456764,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167412674","doi":"10.1177/1352458506071161","title":"Anxiety disorders and their clinical correlates in multiple sclerosis patients","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Anxiety; Psychiatry; Panic disorder; Generalized anxiety disorder; Anxiety disorder; Psychosocial; Agoraphobia; Psychology; Clinical psychology; Social anxiety; Depression (economics); Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1130330942438183,"gpt":0.3198231508235496,"spread":0.2067900565797314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004173159,0.000614373,0.001127511,0.0006533493,0.0007217206,0.0001748393,0.0003699249,0.0004154345,0.0001079027],"category_scores_gemma":[0.005682309,0.0004717904,0.0005255883,0.000746244,0.0007713219,0.0004769936,0.0004302274,0.002098145,0.00004788096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003494374,"about_ca_system_score_gemma":0.0001213168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002068044,"about_ca_topic_score_gemma":0.001742103,"domain_scores_codex":[0.9944751,0.0003691595,0.001857199,0.0008545709,0.0009395246,0.001504507],"domain_scores_gemma":[0.9952692,0.002134105,0.0004537905,0.0005408382,0.0004951771,0.001106824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008900625,0.001103266,0.7323326,0.00003524626,0.000151607,0.000004751768,0.0008125253,0.00001570668,0.004010377,0.000001738105,0.001058414,0.2595837],"study_design_scores_gemma":[0.0174715,0.0006262744,0.9726769,0.0007179465,0.0000458002,0.00002299488,0.001293419,0.00286767,0.0008851114,0.00003434575,0.002902979,0.0004550969],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948046,0.001333563,0.0006444512,0.0007762716,0.0008061331,0.001101493,0.00005037542,0.00009835841,0.0003847679],"genre_scores_gemma":[0.9715176,0.0251815,0.002196502,0.0004212784,0.0004694981,0.0000331733,0.00002899001,0.0000972229,0.00005424941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2591286,"threshold_uncertainty_score":0.9997734,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2895845951","doi":"10.1177/1352458518803785","title":"Recommendations for cognitive screening and management in multiple sclerosis care","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Cognition; Physical medicine and rehabilitation; Intensive care medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.4229201343831565,"gpt":0.4105209539533051,"spread":0.01239918042985144,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001524753,0.001074274,0.002997534,0.001721541,0.001312446,0.0004041037,0.0004749201,0.0005183152,0.0001122601],"category_scores_gemma":[0.002466126,0.000914866,0.001197787,0.0009280079,0.000477946,0.0003575564,0.0006892718,0.001559067,0.00004900039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008057375,"about_ca_system_score_gemma":0.0002467138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007291321,"about_ca_topic_score_gemma":0.0003319109,"domain_scores_codex":[0.9938707,0.000529254,0.001972397,0.001291307,0.0009075664,0.001428738],"domain_scores_gemma":[0.9944155,0.002377654,0.0008944308,0.0005646893,0.001014365,0.000733321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002876233,0.0002596507,0.001757132,0.01256464,0.00150871,0.00001917407,0.0008442462,8.876153e-7,0.000008815021,0.000002609723,0.005597732,0.9771488],"study_design_scores_gemma":[0.01455292,0.0006209693,0.01531727,0.1632542,0.002617373,0.0001185013,0.004065067,0.000329594,0.00001920413,0.000005709352,0.7980216,0.001077603],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003300502,0.9887387,0.001620745,0.0004059244,0.0005443884,0.006988404,0.001018338,0.00009400355,0.0002595103],"genre_scores_gemma":[0.001784336,0.9614542,0.03259915,0.0001488195,0.0009997978,0.001998064,0.0006109377,0.0002391355,0.0001655869],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9760712,"threshold_uncertainty_score":0.9999877,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159596132","doi":"10.1177/1352458514564491","title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":399,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Manitoba Health","funders":"Canadian Institutes of Health Research","keywords":"Comorbidity; Medicine; Incidence (geometry); Epidemiology; Population; MEDLINE; Demography; Environmental health; Psychiatry; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.3153023179724875,"gpt":0.3851511302403983,"spread":0.06984881226791079,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008131574,0.0009273875,0.008158246,0.0005607959,0.0002353123,0.00006153133,0.001446032,0.0003992376,0.00007185337],"category_scores_gemma":[0.02393892,0.0005493737,0.001610417,0.001629602,0.0008697756,0.0002983586,0.001231257,0.00202925,0.00001354694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007225907,"about_ca_system_score_gemma":0.001302273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001638425,"about_ca_topic_score_gemma":0.0001008517,"domain_scores_codex":[0.9882395,0.002895847,0.004647144,0.0007532383,0.002665161,0.000799143],"domain_scores_gemma":[0.9898471,0.002250949,0.004120546,0.001747249,0.001502116,0.0005320902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00003274071,0.0003156766,0.004268409,0.9536906,0.0004832574,0.000007517785,0.0002343736,8.994986e-7,0.00006036981,0.000002223637,0.0006845457,0.04021936],"study_design_scores_gemma":[0.001869568,0.0001845647,0.01939839,0.9702695,0.003596927,0.0002899584,0.00008418912,0.00008205308,0.00002221369,0.000004724199,0.003793939,0.0004040012],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000800119,0.9914653,0.000007180022,0.0001268907,0.0002692334,0.006955802,0.0003185615,0.00002171835,0.00003520888],"genre_scores_gemma":[0.00481149,0.9938102,0.0004764477,0.0001200754,0.0001212786,0.0004948516,0.000009685983,0.00009694137,0.00005898061],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03981536,"threshold_uncertainty_score":0.9996958,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129967156","doi":"10.1177/1352458513507821","title":"Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"IC Design Education Center; National Institutes of Health; Serono Symposia International Foundation; Bayer HealthCare; Acorda Therapeutics; Multiple Sclerosis Society; Biogen; Sanofi; National Multiple Sclerosis Society","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Internal medicine; Discontinuation; Clinical endpoint; Dimethyl fumarate; Physical therapy; Expanded Disability Status Scale; Randomized controlled trial; Immunology; Fingolimod","retraction":null,"screen_n_in":null,"score":{"opus":0.08007616229311648,"gpt":0.2890024800529596,"spread":0.2089263177598432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001668686,0.001002676,0.002676651,0.001017554,0.0007617304,0.0006696999,0.000608525,0.0003542957,0.0008515451],"category_scores_gemma":[0.004402535,0.0007218892,0.0008712678,0.0006900968,0.0004866784,0.001046892,0.0002818845,0.001943178,0.0002032856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001149733,"about_ca_system_score_gemma":0.0003280901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004164772,"about_ca_topic_score_gemma":0.0003075267,"domain_scores_codex":[0.991806,0.0008599728,0.00243877,0.001051629,0.001960136,0.001883476],"domain_scores_gemma":[0.9932647,0.002471398,0.001003885,0.0008861713,0.001240671,0.00113313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8969072,0.003783567,0.04207423,0.0000566929,0.001045723,0.0000580346,0.0007686452,0.0001147147,0.02421548,6.712172e-7,0.00151533,0.02945968],"study_design_scores_gemma":[0.8662965,0.01470312,0.110903,0.001649006,0.0003782136,0.0000308614,0.0005711843,0.003804655,0.000834294,0.000002911316,0.0001456725,0.0006805909],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864265,0.0005456572,0.0002387618,0.0007758016,0.001355856,0.01012526,0.00005379421,0.0001511186,0.0003273007],"genre_scores_gemma":[0.9940148,0.0006825185,0.002618049,0.0001964177,0.0007797004,0.001322013,0.00006642342,0.0001870988,0.0001329807],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06882876,"threshold_uncertainty_score":0.9995232,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114080475","doi":"10.1177/1352458511417835","title":"Multiple sclerosis and depression","year":2011,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Psychosocial; Depression (economics); Medicine; Quality of life (healthcare); Mood; Randomized controlled trial; Psychiatry; Clinical psychology; Mindfulness; Mood disorders; Affect (linguistics); Psychology; Anxiety; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2937370974242926,"gpt":0.3576205899484753,"spread":0.06388349252418274,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001676796,0.001633615,0.00496144,0.001359135,0.001344121,0.0004593203,0.0008553695,0.001092664,0.0005751781],"category_scores_gemma":[0.004635018,0.001183895,0.001922135,0.0008615517,0.0006722048,0.0005128901,0.001186348,0.003664178,0.0003605864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006242589,"about_ca_system_score_gemma":0.0005875727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000143815,"about_ca_topic_score_gemma":0.00006452212,"domain_scores_codex":[0.9920646,0.0008019264,0.00231589,0.001545841,0.001448477,0.001823267],"domain_scores_gemma":[0.9931992,0.001447315,0.001347402,0.00133445,0.000800746,0.001870865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002056364,0.000452653,0.007276527,0.007061326,0.0011328,0.00005763908,0.000340099,3.664613e-7,0.0002252893,0.000002040683,0.006854806,0.9763908],"study_design_scores_gemma":[0.005846506,0.0003672229,0.03265456,0.07911508,0.002398963,0.001096403,0.0001846627,0.0001032784,0.00008307465,0.000008464867,0.8768327,0.001309138],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009530087,0.9943074,0.0001271706,0.00006143488,0.001025285,0.002392932,0.0002053287,0.000222025,0.0007054015],"genre_scores_gemma":[0.00389762,0.9882147,0.004589469,0.0001107453,0.001897213,0.0003922898,0.00009544539,0.0003826118,0.0004198893],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9750817,"threshold_uncertainty_score":0.999956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3018479719","doi":"10.1177/1352458520915629","title":"Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Expert opinion; Physical activity; Physical therapy; Exercise prescription; MEDLINE; Rehabilitation; Physical disability; Disease; Expanded Disability Status Scale; Gerontology; Physical medicine and rehabilitation; Family medicine; Psychology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.1294885872704747,"gpt":0.3447831727304421,"spread":0.2152945854599674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0005597585,0.0005258857,0.0009125391,0.00009540063,0.001860529,0.0003718144,0.0003780987,0.00009467188,0.00006066808],"category_scores_gemma":[0.002093352,0.0003359346,0.0004083933,0.0005412011,0.0004972706,0.0005901472,0.0003011562,0.0009738164,0.00002600563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001368519,"about_ca_system_score_gemma":0.0003149729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001006053,"about_ca_topic_score_gemma":0.0001298226,"domain_scores_codex":[0.9967341,0.0002296556,0.0004321766,0.0007375833,0.0009534201,0.0009130112],"domain_scores_gemma":[0.9955555,0.001520537,0.0003309419,0.0005447611,0.0006073821,0.001440851],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01427908,0.004712525,0.6097398,0.0007688429,0.001550972,0.00002652208,0.01477696,0.0005040328,0.06086143,0.00003616516,0.05936437,0.2333793],"study_design_scores_gemma":[0.01133734,0.0007744331,0.9292379,0.001032663,0.0007532671,0.00002159244,0.001909528,0.04751277,0.00323334,0.00001595954,0.003686564,0.0004846267],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9062737,0.0008623879,0.003268009,0.08606944,0.0001799112,0.002673307,0.0004867212,0.000154513,0.00003195926],"genre_scores_gemma":[0.9885469,0.004311423,0.004194329,0.0010213,0.001114791,0.0005892004,0.00004342557,0.0001134182,0.00006518421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3194981,"threshold_uncertainty_score":0.9999093,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2001110565","doi":"10.1177/1352458514538110","title":"Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; European Committee for Treatment and Research in Multiple Sclerosis","keywords":"Kappa; Optical coherence tomography; Clinically isolated syndrome; Medicine; Medical physics; Test (biology); Retinal; Cohen's kappa; Computer science; Artificial intelligence; Optometry; Multiple sclerosis; Ophthalmology; Mathematics; Machine learning","retraction":null,"screen_n_in":null,"score":{"opus":0.176711262562985,"gpt":0.3528978875698814,"spread":0.1761866250068964,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005928964,0.000451311,0.001197319,0.00036555,0.0006738749,0.0001516768,0.0006324373,0.0002418677,0.0001192569],"category_scores_gemma":[0.01831509,0.000323398,0.0007753882,0.000564751,0.000474103,0.0003389008,0.0002033694,0.0008862515,0.00001257309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003730474,"about_ca_system_score_gemma":0.0001967561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002817874,"about_ca_topic_score_gemma":0.0004017623,"domain_scores_codex":[0.9939102,0.001334554,0.001780069,0.0006015758,0.001387353,0.0009862275],"domain_scores_gemma":[0.9939299,0.002789813,0.0008867559,0.0008544818,0.001159145,0.0003799277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002052878,0.0005330602,0.5111188,0.0002454841,0.0001686161,7.007599e-7,0.0006691163,0.0002738373,0.4714285,0.00003858705,0.00201098,0.0114594],"study_design_scores_gemma":[0.02101894,0.0004395498,0.910144,0.001453358,0.0001055653,0.00001651931,0.000411347,0.0118613,0.05324403,0.0001362865,0.0008628365,0.0003063223],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984802,0.0002691838,0.008092131,0.003382712,0.0008382639,0.002105111,0.0001984023,0.00005537421,0.0002568432],"genre_scores_gemma":[0.9940426,0.0002610301,0.004124875,0.0004184459,0.0007397884,0.0002482959,0.00002029695,0.00007280015,0.00007190254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4181845,"threshold_uncertainty_score":0.9999218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2173315418","doi":"10.1177/1352458515616701","title":"Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"IC Design Education Center; Biogen; Allergan; Eli Lilly and Company","keywords":"Multiple sclerosis; Relapsing remitting; Medicine; Inclusion (mineral); Brain size; Disease; Psychology; Pathology; Magnetic resonance imaging; Immunology; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.1232556374163051,"gpt":0.3199593105743067,"spread":0.1967036731580015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005946844,0.0005335912,0.001803771,0.001280121,0.0002905109,0.00002842081,0.0007113281,0.0002729545,0.0001700812],"category_scores_gemma":[0.04096458,0.0004011985,0.000624007,0.001451567,0.0007573182,0.0009157164,0.00127879,0.0009618241,0.00001268505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008244268,"about_ca_system_score_gemma":0.0006420178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000609352,"about_ca_topic_score_gemma":0.0003955936,"domain_scores_codex":[0.9922515,0.001206461,0.002356391,0.0007609277,0.002402391,0.001022303],"domain_scores_gemma":[0.991362,0.003811594,0.001603303,0.0009428346,0.001637966,0.0006423067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.009114608,0.0007252503,0.4442908,0.0006856593,0.00007012208,0.0000123103,0.000862708,0.00005961266,0.5136387,0.000001089396,0.0002214071,0.03031771],"study_design_scores_gemma":[0.01354495,0.001229411,0.8733614,0.06257997,0.0000728552,0.000008129951,0.0001663473,0.003243398,0.04537046,0.00002072716,0.00005307291,0.0003492676],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907156,0.002847347,0.0006019492,0.004243147,0.000212308,0.001215139,0.00008399048,0.00003073849,0.00004981345],"genre_scores_gemma":[0.990549,0.006497801,0.002467149,0.00007227808,0.0001776281,0.00005542875,0.000002704451,0.00008300121,0.00009503264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4682683,"threshold_uncertainty_score":0.999844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040728132","doi":"10.1177/1352458506071174","title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Neuromyelitis optica; Optic neuritis; Medicine; Myelitis; Multiple sclerosis; Methylprednisolone; Central nervous system; Autoantibody; Transverse myelitis; Immunology; Internal medicine; Gastroenterology; Spinal cord; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.05910347157856551,"gpt":0.2871247364376635,"spread":0.228021264859098,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001133624,0.0003762718,0.0007636956,0.0006568799,0.0002306357,0.00005605612,0.0002713086,0.0001349692,0.0001568442],"category_scores_gemma":[0.001024088,0.0002734481,0.0002198046,0.0007113947,0.0003637855,0.000244187,0.0001408911,0.0009081701,0.00002016687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003371363,"about_ca_system_score_gemma":0.0001245468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009635323,"about_ca_topic_score_gemma":0.0001842577,"domain_scores_codex":[0.996105,0.0001892743,0.000876551,0.0004305508,0.001322773,0.001075903],"domain_scores_gemma":[0.9968636,0.00115825,0.0003436796,0.0003792434,0.0007380383,0.0005171669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004404297,0.00171896,0.8117411,0.00009513092,0.0003260329,0.00007985872,0.001808363,0.00005947917,0.02118215,0.000008582527,0.0001176303,0.1584584],"study_design_scores_gemma":[0.02031087,0.001575754,0.9678652,0.0009970339,0.0000720042,0.00003514139,0.0002890766,0.0003345481,0.007971997,0.000003672587,0.0002979662,0.0002467449],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966295,0.0003258213,0.0004819314,0.0004508102,0.0001765936,0.001004784,0.00004296787,0.0000337038,0.0008539308],"genre_scores_gemma":[0.9960324,0.0006626677,0.002736622,0.0001732334,0.0002363488,0.00001946125,0.00001811159,0.00006801976,0.00005309259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1582117,"threshold_uncertainty_score":0.9999717,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965997336","doi":"10.1177/1352458512460605","title":"Scoring treatment response in patients with relapsing multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":257,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1270508831604888,"gpt":0.2940942887571419,"spread":0.1670434055966531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002012037,0.0006763335,0.001021819,0.000947013,0.0008149003,0.0002015468,0.0002834017,0.0002126465,0.0001773301],"category_scores_gemma":[0.002689933,0.0004953651,0.0003463114,0.0008959273,0.0002788757,0.001043769,0.0002001751,0.0009882881,0.0001152938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002273337,"about_ca_system_score_gemma":0.0002381868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002364847,"about_ca_topic_score_gemma":0.000140227,"domain_scores_codex":[0.9941947,0.0006456948,0.001030383,0.0006181349,0.001538137,0.001972934],"domain_scores_gemma":[0.996088,0.001116634,0.0003885908,0.0007250859,0.0004994482,0.001182216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01480882,0.002383608,0.9250183,0.00003364711,0.0002842747,0.00001529342,0.00197473,0.0001413892,0.02862048,9.705504e-7,0.0002516371,0.02646683],"study_design_scores_gemma":[0.02822133,0.002051565,0.9610549,0.001917804,0.0001165189,0.00003165639,0.0006102417,0.0005322446,0.004193092,0.000001152378,0.0007730275,0.0004964481],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960852,0.001004614,0.0001968271,0.0005534513,0.0005254654,0.001305911,0.00004157807,0.000114953,0.0001720346],"genre_scores_gemma":[0.990511,0.00111129,0.007210986,0.0001442485,0.000573836,0.0001390238,0.0000230096,0.0001440119,0.0001425821],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03603661,"threshold_uncertainty_score":0.9997498,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146662840","doi":"10.1177/1352458506070775","title":"MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis","year":2006,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Observational study; Epidemiology; Medicine; Strengthening the reporting of observational studies in epidemiology; Cohort; Disease registry; Cohort study; Data sharing; Population; Family medicine; MEDLINE; Disease; Alternative medicine; Pathology; Environmental health; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.3314225773228368,"gpt":0.4164774766360156,"spread":0.08505489931317883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002988477,0.0004981649,0.0009543844,0.001273266,0.001051393,0.0005072883,0.0005908663,0.000298596,0.0000776996],"category_scores_gemma":[0.004240683,0.0004193825,0.0002501344,0.001001898,0.0007193843,0.001097786,0.0003449132,0.001469489,0.00001199672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008341905,"about_ca_system_score_gemma":0.0003750901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001265715,"about_ca_topic_score_gemma":0.005791787,"domain_scores_codex":[0.9944836,0.0003123204,0.001235079,0.0008925147,0.00176083,0.001315648],"domain_scores_gemma":[0.9941763,0.002148745,0.0003543772,0.0006569945,0.002056243,0.0006073937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001953723,0.002048625,0.8877503,0.0001163211,0.0002391004,0.00004148308,0.0007379416,0.0001712528,0.07479333,0.00006797774,0.004868363,0.02721157],"study_design_scores_gemma":[0.01684116,0.0006865125,0.9604632,0.0008884414,0.00003899469,0.00004892649,0.00403482,0.00918043,0.002640489,0.0001497723,0.00462456,0.0004027023],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906428,0.0008746436,0.0002337405,0.004679776,0.00042935,0.0018502,0.0008058853,0.00008291811,0.0004006111],"genre_scores_gemma":[0.9743502,0.003788301,0.01952949,0.0002152973,0.001044754,0.0003098537,0.0002773598,0.0001011425,0.0003835971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07271288,"threshold_uncertainty_score":0.9998258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102772856","doi":"10.1177/1352458508091367","title":"Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; University of Calgary","funders":"National Eye Institute; Baker Foundation; Ottawa Hospital Research Institute; Biogen; Research to Prevent Blindness","keywords":"Nerve fiber layer; Optic neuritis; Retinal; Optic nerve; Medicine; Ophthalmology; Optical coherence tomography; Nerve fiber; Retina; Anatomy; Multiple sclerosis; Neuroscience; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1223950384408844,"gpt":0.3239649818240625,"spread":0.2015699433831781,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000994482,0.0006190328,0.001039155,0.0005605522,0.001212174,0.0002706595,0.0003892737,0.0001919011,0.0006756207],"category_scores_gemma":[0.001209995,0.000521691,0.0006109345,0.0009712842,0.0009859777,0.0006592551,0.0003377704,0.001888686,0.00008826447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004406303,"about_ca_system_score_gemma":0.000263245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001264319,"about_ca_topic_score_gemma":0.00005174656,"domain_scores_codex":[0.9941988,0.0004043807,0.001096405,0.000913667,0.002007174,0.001379557],"domain_scores_gemma":[0.9965992,0.0003924739,0.0002977947,0.0006077347,0.001223525,0.000879263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001868588,0.002271479,0.9598287,0.00006393882,0.0005695843,0.003508239,0.004072771,0.0001151079,0.02451698,0.000001151565,0.0002636461,0.002919812],"study_design_scores_gemma":[0.008373651,0.001519408,0.9774415,0.0009019285,0.0002734953,0.004018121,0.00171784,0.001216415,0.003947933,0.00000833483,0.00006212256,0.0005192471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959152,0.0009498881,0.0002482063,0.0002682398,0.0002769025,0.001894256,0.00002702402,0.000125493,0.0002948161],"genre_scores_gemma":[0.9874448,0.0002416871,0.01077993,0.0001023196,0.0009332462,0.0002310337,0.000003164832,0.0001113518,0.0001524891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02056904,"threshold_uncertainty_score":0.9997235,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107480122","doi":"10.1177/1352458508099477","title":"The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases","keywords":"Multiple sclerosis; Comorbidity; Medicine; MEDLINE; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.144334292568887,"gpt":0.3132539869279423,"spread":0.1689196943590553,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001440787,0.0004460122,0.0008365777,0.0003833192,0.000993549,0.0002052132,0.0004067415,0.0001922816,0.00005815857],"category_scores_gemma":[0.00204878,0.0003141389,0.0002983767,0.0006113015,0.0006896511,0.0003277635,0.0002021275,0.001022465,0.0000137038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004719186,"about_ca_system_score_gemma":0.0001682763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009224545,"about_ca_topic_score_gemma":0.0006924786,"domain_scores_codex":[0.9958838,0.0004028963,0.001114709,0.0005056309,0.001106038,0.0009868983],"domain_scores_gemma":[0.9969248,0.001238785,0.0003990974,0.0005470184,0.0003695942,0.0005207567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002001339,0.001275884,0.4341117,0.0000825361,0.0005337014,0.00006177893,0.003729224,0.0003292054,0.4119036,0.00005015323,0.007947919,0.1379729],"study_design_scores_gemma":[0.01372162,0.0007428596,0.9616232,0.001264809,0.00007611154,0.0001056516,0.003040393,0.006526672,0.01140554,0.0001558821,0.001015188,0.0003220651],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853087,0.004068131,0.00006990979,0.008804373,0.0002426292,0.001050285,0.00005615222,0.00006093108,0.0003388931],"genre_scores_gemma":[0.9724939,0.02600028,0.0008052205,0.0002059801,0.0003240716,0.00003606325,0.00001630703,0.00004158129,0.00007656046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5275114,"threshold_uncertainty_score":0.9999311,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118969721","doi":"10.1177/1352458509359727","title":"The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Ottawa Hospital; Montreal Neurological Institute and Hospital; University of Ottawa","funders":"Multiple Sclerosis Society","keywords":"Mesenchymal stem cell; Multiple sclerosis; Remyelination; Stem cell; Medicine; Transplantation; Stem-cell therapy; Regenerative medicine; Regeneration (biology); Cell therapy; Immunology; Pathology; Central nervous system; Biology; Surgery; Internal medicine; Myelin","retraction":null,"screen_n_in":null,"score":{"opus":0.1051247899443715,"gpt":0.3116131518542254,"spread":0.206488361909854,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001975074,0.0002735356,0.0004626548,0.0001502344,0.0005770627,0.0001031318,0.0005351581,0.0001349964,0.00008487652],"category_scores_gemma":[0.0002811594,0.0001499255,0.0005586965,0.0002200543,0.0002976439,0.00007800641,0.00006762844,0.0005502802,0.000004837514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001526307,"about_ca_system_score_gemma":0.0003676075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003822848,"about_ca_topic_score_gemma":0.0006716948,"domain_scores_codex":[0.9963278,0.000286546,0.001158055,0.0003587977,0.001427075,0.0004417545],"domain_scores_gemma":[0.9966189,0.00103813,0.0007989458,0.0005998774,0.0007338624,0.0002102922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002845151,0.001678685,0.143526,0.00005647464,0.0005323159,0.0000564452,0.001301787,0.00007735576,0.8323443,0.00001775156,0.000109115,0.01745457],"study_design_scores_gemma":[0.01817648,0.002581042,0.6773794,0.0002638,0.0006225763,0.001460394,0.004419028,0.004316929,0.2897862,0.00004231521,0.0007351524,0.0002166331],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943557,0.0002541264,0.0003148241,0.0009277617,0.001450876,0.002357993,0.00006802673,0.00001692465,0.0002537188],"genre_scores_gemma":[0.9979078,0.0003479339,0.0006090481,0.00002911396,0.0003074432,0.0001353085,0.00001248274,0.00004335137,0.0006075646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5425581,"threshold_uncertainty_score":0.6113784,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163795029","doi":"10.1177/1352458511430704","title":"Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's Hospital of Eastern Ontario; SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Multiple sclerosis; MEDLINE; Food and drug administration; Intensive care medicine; Family medicine; Orphan drug; Pathology; Psychiatry; Pharmacology; Bioinformatics","retraction":null,"screen_n_in":null,"score":{"opus":0.5914290582407363,"gpt":0.3944436485362681,"spread":0.1969854097044683,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003778727,0.0003915321,0.000729982,0.000473109,0.0005494516,0.00008123243,0.0002235772,0.0001631592,0.0001654939],"category_scores_gemma":[0.003891655,0.0003346896,0.0002955477,0.000406116,0.000249515,0.000189342,0.0001515136,0.0004594153,0.000007509741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002546124,"about_ca_system_score_gemma":0.0005178382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002898115,"about_ca_topic_score_gemma":0.0001286177,"domain_scores_codex":[0.9956497,0.0003104255,0.001272119,0.0004970778,0.001491087,0.0007796035],"domain_scores_gemma":[0.9952669,0.0009704632,0.0007725415,0.0004006016,0.002033205,0.0005562959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001719219,0.0006729176,0.6973193,0.000324278,0.0007369986,0.000002772882,0.005185877,0.00006691221,0.1039484,0.00001749109,0.002662259,0.1873435],"study_design_scores_gemma":[0.02092145,0.0008679486,0.934856,0.0004343991,0.001197334,0.00003499598,0.002024506,0.0219506,0.01676493,0.0001712149,0.0004093986,0.0003672007],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914153,0.003572589,0.001793762,0.000380761,0.0002985509,0.001973562,0.0001052182,0.00005733231,0.0004029909],"genre_scores_gemma":[0.9562559,0.004480741,0.03832565,0.0001068966,0.0005643633,0.00009481247,0.00001516748,0.0000745778,0.00008185791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2375367,"threshold_uncertainty_score":0.9999105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025694051","doi":"10.1177/1352458507084264","title":"Natural history of secondary-progressive multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Age of onset; Expanded Disability Status Scale; Natural history; Population; Pediatrics; Internal medicine; Disease; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1403743896609519,"gpt":0.2852502946868039,"spread":0.1448759050258519,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008985046,0.0006711247,0.001452761,0.0007905532,0.0007018901,0.00004853259,0.0006680369,0.0002861455,0.001560216],"category_scores_gemma":[0.003665073,0.0005662022,0.0009854207,0.0005518938,0.001574591,0.0006342621,0.0004105458,0.00211713,0.0001191692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001739031,"about_ca_system_score_gemma":0.001244585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002385823,"about_ca_topic_score_gemma":0.00006476218,"domain_scores_codex":[0.9940178,0.0003395264,0.001510933,0.0007625159,0.002045589,0.001323568],"domain_scores_gemma":[0.9948983,0.0008116578,0.000900274,0.0008816178,0.001589709,0.0009184082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001870074,0.001242412,0.285618,0.0002571875,0.0009880844,0.0002585446,0.003693926,0.00003735714,0.5620012,0.000006319221,0.09726436,0.04676249],"study_design_scores_gemma":[0.01394607,0.0006906725,0.9439108,0.001146986,0.0001486708,0.0009999448,0.0006164789,0.002367654,0.02252158,0.000006666798,0.01303267,0.0006117591],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.972073,0.02193632,0.0001447747,0.0007731756,0.001998174,0.0009499317,0.00008788568,0.0001730371,0.001863665],"genre_scores_gemma":[0.9814494,0.007082699,0.00788601,0.0004647104,0.0009049863,0.000085634,0.00003596968,0.0001281134,0.001962488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6582928,"threshold_uncertainty_score":0.999679,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2905522261","doi":"10.1177/1352458518814117","title":"Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Multiple sclerosis; Magnetic resonance imaging; Medicine; Pathology; Neuroscience; Nuclear magnetic resonance; Radiology; Physics; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.0872391206309767,"gpt":0.3193916743796263,"spread":0.2321525537486496,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00152098,0.0007884648,0.001307201,0.001038469,0.002093555,0.0002532325,0.0008143999,0.0002615744,0.002599814],"category_scores_gemma":[0.008145767,0.0006908212,0.0008071204,0.001323773,0.0015903,0.0008402842,0.000794452,0.001573567,0.0002918712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001258705,"about_ca_system_score_gemma":0.0008178128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006027038,"about_ca_topic_score_gemma":0.0004417844,"domain_scores_codex":[0.9929196,0.0004904371,0.001610889,0.001081033,0.002011209,0.001886832],"domain_scores_gemma":[0.9933917,0.001585361,0.0007291037,0.001118758,0.002092408,0.001082674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001190054,0.0007169595,0.1677069,0.000106071,0.0001843778,0.00004046782,0.001517141,0.00001141039,0.5144641,0.000009230904,0.008599844,0.3054535],"study_design_scores_gemma":[0.01014643,0.00131821,0.9046993,0.004859926,0.0002096549,0.0002080601,0.001428877,0.01217695,0.05945323,0.0000414588,0.004820559,0.0006373329],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9739991,0.01712564,0.001124124,0.001989987,0.001034099,0.001576994,0.0002065851,0.0002202909,0.002723203],"genre_scores_gemma":[0.9800885,0.008744198,0.008205606,0.0002912903,0.001606862,0.0001513315,0.00001623775,0.000179446,0.0007165135],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7369924,"threshold_uncertainty_score":0.9995543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988098374","doi":"10.1191/1352458505ms1190oa","title":"The mechanism of action of methylprednisolone in the treatment of multiple sclerosis","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Multiple sclerosis; Methylprednisolone; Immune system; Nitric oxide; Medicine; Mechanism (biology); Tumor necrosis factor alpha; Disease; Immunology; Apoptosis; Mechanism of action; Extravasation; Inflammation; Cytokine; Microglia; Neuroscience; Pharmacology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3692665200133362,"gpt":0.4033581294156865,"spread":0.03409160940235029,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00312518,0.0008474112,0.004056443,0.0008587869,0.0004775185,0.00006794617,0.001050817,0.0004919745,0.00006934622],"category_scores_gemma":[0.002040739,0.0004320278,0.002392653,0.001239197,0.0007049933,0.0001693889,0.0001685336,0.001140911,0.00001122872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007995754,"about_ca_system_score_gemma":0.0005439242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005418524,"about_ca_topic_score_gemma":0.0008314714,"domain_scores_codex":[0.9916627,0.001649593,0.00327867,0.0005687413,0.001935887,0.0009043406],"domain_scores_gemma":[0.9896998,0.005177636,0.002824847,0.00133867,0.0007215249,0.0002374555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003830368,0.00209989,0.0005804612,0.002573484,0.001547773,0.000005023192,0.001537088,0.00001914801,0.006047766,0.00001790714,0.0002473513,0.9849411],"study_design_scores_gemma":[0.02911505,0.009749764,0.04595695,0.08459628,0.009385594,0.0003839876,0.007069389,0.001512743,0.01940264,0.00008249872,0.7909804,0.001764706],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008915841,0.9867856,0.0001059795,0.0002855607,0.0004226857,0.003116079,0.0002634621,0.00001918054,0.00008564742],"genre_scores_gemma":[0.08551031,0.9120058,0.001420697,0.0000128289,0.0004880302,0.0003614833,0.00003153499,0.00009605219,0.00007319879],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9831764,"threshold_uncertainty_score":0.9998131,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991460270","doi":"10.1177/1352458507080733","title":"Validation of the Multiple Sclerosis International Quality of Life questionnaire","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Merck KGaA","keywords":"Quality of life (healthcare); Checklist; Construct validity; Discriminant validity; Reliability (semiconductor); Scale (ratio); External validity; Multiple sclerosis; Medicine; Clinical psychology; Psychometrics; Psychology; Physical therapy; Internal consistency; Psychiatry; Social psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.1751854466491057,"gpt":0.3521559668013095,"spread":0.1769705201522038,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004328997,0.0003085342,0.0007508993,0.0004096832,0.0004192418,0.00005856089,0.0006583633,0.0001921453,0.0001937477],"category_scores_gemma":[0.01548875,0.0002207496,0.0006707733,0.0006716201,0.0005884608,0.0003441024,0.0003459018,0.0007597047,0.00001267425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003478076,"about_ca_system_score_gemma":0.0002967845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004455334,"about_ca_topic_score_gemma":0.0002171569,"domain_scores_codex":[0.9945825,0.0003954147,0.001916699,0.0003693335,0.002165898,0.000570189],"domain_scores_gemma":[0.994773,0.0009259731,0.001298469,0.0006504084,0.001926317,0.0004258018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007360947,0.0004581707,0.6148784,0.00009424518,0.0002704948,7.041024e-7,0.0005053653,0.0001585408,0.3711779,0.00002540108,0.0006433463,0.01105144],"study_design_scores_gemma":[0.004867007,0.0001175848,0.8182815,0.0009895378,0.00005303695,0.000011008,0.0005310517,0.0005059929,0.174266,0.00002315429,0.0001954789,0.0001586398],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919245,0.0004500749,0.003404758,0.00194163,0.001097476,0.0006178568,0.00007779495,0.0000445545,0.0004413685],"genre_scores_gemma":[0.9950643,0.0008330198,0.003176431,0.0001824155,0.0005817236,0.00001621076,0.00001387245,0.0000423731,0.00008960797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2034032,"threshold_uncertainty_score":0.9928042,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041554374","doi":"10.1191/1352458505ms1168oa","title":"Severity of chronic pain and its relationship to quality of life in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Medicine; Chronic pain; Depression (economics); Quality of life (healthcare); Multiple sclerosis; McGill Pain Questionnaire; Physical therapy; Anxiety; Osteoarthritis; Rheumatoid arthritis; Internal medicine; Pain catastrophizing; Visual analogue scale; Psychiatry; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.2403712403511937,"gpt":0.3494604324301012,"spread":0.1090891920789075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005849973,0.0003623391,0.001221859,0.0007281701,0.0002903146,0.0000441178,0.0003100682,0.000221082,0.0001605005],"category_scores_gemma":[0.02405809,0.0003323674,0.0002926004,0.0009038849,0.0002570082,0.0003961336,0.0002901207,0.000911753,0.00002127928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005640366,"about_ca_system_score_gemma":0.0003650488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005403085,"about_ca_topic_score_gemma":0.002728081,"domain_scores_codex":[0.994622,0.001005325,0.00192884,0.0005056177,0.00117996,0.0007582369],"domain_scores_gemma":[0.9948657,0.002523865,0.0006128725,0.0004794576,0.0007213236,0.0007967947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007376894,0.0006718267,0.8032073,0.0003635448,0.0001152646,0.000001183909,0.00117819,0.0006553927,0.1613162,0.00001502527,0.0005541314,0.03118425],"study_design_scores_gemma":[0.007755561,0.0005277974,0.9683512,0.001381519,0.00003205896,0.000006190824,0.0004729714,0.0126401,0.008317756,0.00001037653,0.0002290555,0.0002753928],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923987,0.002939471,0.0005354345,0.002829145,0.00009631852,0.0009824251,0.00009579085,0.00003517892,0.00008754305],"genre_scores_gemma":[0.992012,0.001704171,0.005491813,0.0002691056,0.0003524444,0.00005963324,0.000008382032,0.00004761507,0.00005483148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1651439,"threshold_uncertainty_score":0.9999129,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146793337","doi":"10.1177/1352458508092263","title":"Comorbidity, socioeconomic status and multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases","keywords":"Comorbidity; Medicine; Socioeconomic status; Odds ratio; Odds; Population; Multiple sclerosis; Internal medicine; Psychiatry; Logistic regression; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.170241758578428,"gpt":0.3037435392962886,"spread":0.1335017807178605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.000937514,0.0006254604,0.001152741,0.0005397166,0.002037892,0.0002267183,0.000351123,0.0002745886,0.0006670074],"category_scores_gemma":[0.001680841,0.0005558009,0.0004914789,0.0002967338,0.001133814,0.0006216688,0.0005105415,0.001461621,0.0003439068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006476531,"about_ca_system_score_gemma":0.0003689805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005317482,"about_ca_topic_score_gemma":0.0002039388,"domain_scores_codex":[0.99512,0.0002822761,0.001080643,0.0008042757,0.001059723,0.001653107],"domain_scores_gemma":[0.9959862,0.0008757946,0.0004045067,0.0006425441,0.0005310136,0.001559933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004938858,0.0004712081,0.8862069,0.00007246022,0.0004121565,0.00005744481,0.001400147,0.00004856863,0.07893522,0.000005684498,0.01384131,0.01805505],"study_design_scores_gemma":[0.01172572,0.0004498581,0.9721909,0.0003266493,0.00009991061,0.0005894481,0.0006620895,0.002801899,0.005003768,0.00002362176,0.005586017,0.0005401514],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930681,0.002652519,0.0001674225,0.001875955,0.0005310249,0.0007950727,0.0001079274,0.0001882283,0.0006137699],"genre_scores_gemma":[0.949599,0.04393969,0.004421031,0.0006348303,0.0008863016,0.00004514457,0.00002895366,0.0001199813,0.0003251002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.085984,"threshold_uncertainty_score":0.9996893,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978928514","doi":"10.1177/1352458513507822","title":"Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neuromyelitis optica; Hiccups; Population; Vertigo; Vomiting; Pediatrics; Brainstem; Trigeminal neuralgia; Ataxia; Optic neuritis; Multiple sclerosis; Anesthesia; Internal medicine; Surgery; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.0800234183058476,"gpt":0.293007724955086,"spread":0.2129843066492384,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004454827,0.000303795,0.0006287808,0.0005987966,0.0002379524,0.0001085609,0.0002791459,0.00008258824,0.0003597599],"category_scores_gemma":[0.001999067,0.0002439594,0.000188649,0.0004618902,0.0001393607,0.0004753191,0.0002168848,0.0007102916,0.00009440909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002207729,"about_ca_system_score_gemma":0.00007277966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007530557,"about_ca_topic_score_gemma":0.0003681434,"domain_scores_codex":[0.99633,0.0003438619,0.001166611,0.0003999719,0.00108227,0.0006772701],"domain_scores_gemma":[0.9973425,0.0004866722,0.0003222582,0.0004267021,0.001003184,0.0004187129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001679947,0.004326285,0.9658713,0.00006844587,0.0001538099,0.00003360254,0.00393436,0.00009655675,0.009628984,0.000001249535,0.000767072,0.01495033],"study_design_scores_gemma":[0.01699267,0.001199775,0.9729584,0.0004215686,0.00004343632,0.00001452973,0.00495101,0.002915811,0.0002651159,0.000004144322,0.00005368032,0.0001798775],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963048,0.00005016049,0.0000391718,0.0005710306,0.0002330486,0.00232582,0.00002192972,0.00003252796,0.0004215203],"genre_scores_gemma":[0.9975134,0.0002274438,0.001662325,0.0001324774,0.0001246904,0.0001951525,0.000009420438,0.00004986816,0.00008518805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01682468,"threshold_uncertainty_score":0.9948374,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2169229493","doi":"10.1177/1352458514564490","title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Medical Center, University of Rochester; EMD Serono; National Institutes of Health; MedDay Pharmaceuticals; Technische Universität München; Università degli Studi di Genova; Gentofte Hospital; Bayer HealthCare; Institut National de la Santé et de la Recherche Médicale; Multiple Sclerosis Society of Canada; Cleveland Clinic Foundation; Ironwood Pharmaceuticals, Incorporated; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Children's Hospital of Philadelphia; NYU Langone Medical Center; Teva Pharmaceutical Industries; University of Rochester; Pfizer; Biogen; Gilead Sciences; Yale University; Eli Lilly and Company; U.S. Department of Defense; Sanofi; University College London; Cleveland Clinic; Canadian Institutes of Health Research; Amylin Pharmaceuticals; Genentech; Vrije Universiteit Amsterdam; National Multiple Sclerosis Society","keywords":"Medicine; Incidence (geometry); Disease; Population; Multiple sclerosis; Psoriasis; MEDLINE; Comorbidity; Epidemiology; Internal medicine; Immunology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1307681602214866,"gpt":0.3403496209956891,"spread":0.2095814607742024,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005173525,0.0009204342,0.007374334,0.0006602793,0.0003110376,0.00006538859,0.00140448,0.0002995314,0.00007511721],"category_scores_gemma":[0.03407938,0.0005474674,0.001965278,0.00134878,0.0009367379,0.000235327,0.001057332,0.001741767,0.00001274583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004628172,"about_ca_system_score_gemma":0.0009008414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001245233,"about_ca_topic_score_gemma":0.00003645344,"domain_scores_codex":[0.989037,0.002471385,0.004740847,0.0007805506,0.002154283,0.0008159581],"domain_scores_gemma":[0.9893614,0.003254287,0.004014203,0.001921276,0.0008825008,0.0005663098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00005686428,0.0002931016,0.01244957,0.9561732,0.0004733217,0.000006581852,0.0001353992,0.000002623898,0.0001566805,0.00000240499,0.0001526072,0.03009759],"study_design_scores_gemma":[0.001508253,0.0001168683,0.1122302,0.8803762,0.003832661,0.00006967007,0.00002386996,0.0003180909,0.00001436418,0.000002688178,0.001133633,0.0003735394],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001416389,0.9913924,0.00002712209,0.0001889567,0.0002354023,0.006476391,0.0002221906,0.00002468357,0.00001643406],"genre_scores_gemma":[0.02557652,0.9729701,0.0004156762,0.0001091027,0.00010849,0.0006008312,0.00001014449,0.0001083662,0.0001007529],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.09978059,"threshold_uncertainty_score":0.9996977,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164267257","doi":"10.1177/1352458509359725","title":"Neurofilament light as a prognostic marker in multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Biogen; IC Design Education Center; Ministère de la Santé et des Services sociaux; Sanofi","keywords":"Multiple sclerosis; Neurofilament; Medicine; Cerebrospinal fluid; Confidence interval; Odds ratio; Internal medicine; Lumbar puncture; Pathology; Amyotrophic lateral sclerosis; Central nervous system disease; Gastroenterology; Disease; Immunology; Immunohistochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.0951121904387074,"gpt":0.2952546373115432,"spread":0.2001424468728358,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002004792,0.0007776696,0.001155595,0.001064249,0.0008236306,0.0004424056,0.0007087886,0.0003949793,0.001426858],"category_scores_gemma":[0.0105292,0.0006514864,0.0006120026,0.001117974,0.0004232521,0.0005736716,0.000517383,0.00359549,0.0006281345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000383997,"about_ca_system_score_gemma":0.0004304803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003944804,"about_ca_topic_score_gemma":0.001322894,"domain_scores_codex":[0.9931401,0.0003931172,0.001508469,0.001050321,0.002008392,0.001899596],"domain_scores_gemma":[0.9953119,0.001149879,0.0004384328,0.001019901,0.0007216662,0.001358184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006738544,0.0009570131,0.5273648,0.00006346757,0.0001355643,0.0001283622,0.0005333911,0.00001708776,0.4487155,0.000008088518,0.003072664,0.01833024],"study_design_scores_gemma":[0.0113743,0.0005938288,0.9552562,0.001050693,0.0001003642,0.0004000847,0.0004259999,0.003442956,0.01924948,0.00003202215,0.007469197,0.0006048418],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880457,0.0004490897,0.0000645682,0.00600033,0.001423106,0.001891055,0.00003014651,0.0001853617,0.001910674],"genre_scores_gemma":[0.9900106,0.001872108,0.005198542,0.0008775492,0.001040461,0.0003403879,0.00001985738,0.0001679183,0.0004725818],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.429466,"threshold_uncertainty_score":0.9995936,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054962526","doi":"10.1177/1352458513507816","title":"Predictors and dynamics of postpartum relapses in women with multiple sclerosis","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Notre-Dame","funders":"Medical Research Council; Novartis Pharma; Sanofi","keywords":"Medicine; Pregnancy; Multiple sclerosis; Postpartum period; Observational study; Obstetrics; Logistic regression; Expanded Disability Status Scale; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04471579156247234,"gpt":0.2505004825673269,"spread":0.2057846910048546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009143866,0.0004909877,0.001070512,0.0007326441,0.0003168627,0.0001652741,0.0003142591,0.0002101072,0.0003033403],"category_scores_gemma":[0.001498778,0.0003674493,0.0001410922,0.0007351546,0.0007140015,0.0006831824,0.0002195151,0.001031537,0.00002296379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006689716,"about_ca_system_score_gemma":0.0001827481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008057973,"about_ca_topic_score_gemma":0.0008455983,"domain_scores_codex":[0.9957753,0.0002282062,0.001073012,0.0005748993,0.001154133,0.001194445],"domain_scores_gemma":[0.9967545,0.0007220852,0.0004342195,0.0005135986,0.0007251529,0.0008504944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001430126,0.0005684171,0.924612,0.0001868875,0.0003354079,0.0000141533,0.002419962,0.00008605519,0.04798723,0.000004755876,0.0008464774,0.02150848],"study_design_scores_gemma":[0.009929307,0.001339927,0.9721174,0.001796662,0.00005398351,0.0000895974,0.003680148,0.008680333,0.001859123,0.00002375127,0.00008544342,0.0003442717],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956334,0.0006221324,0.0001367565,0.001929962,0.0001441561,0.001194303,0.00007270254,0.00006602443,0.000200568],"genre_scores_gemma":[0.9888945,0.006257145,0.004082611,0.0001677061,0.0001430673,0.0002424364,0.00001377887,0.00008975298,0.0001090695],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0475054,"threshold_uncertainty_score":0.9998778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2583347849","doi":"10.1177/1352458517690618","title":"Age Related Multiple Sclerosis Severity Score: Disability ranked by age","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia Hospital","funders":"Neuroförbundet; National Institute for Health and Care Research; Biogen","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Severity of illness; Physical therapy; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.1489694079172029,"gpt":0.3204461257698196,"spread":0.1714767178526167,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["sts"],"category_scores_codex":[0.003185828,0.001061196,0.001968367,0.0002548913,0.005287986,0.001512163,0.001798629,0.0006169475,0.0008693527],"category_scores_gemma":[0.01195189,0.0009076084,0.001242732,0.0004227343,0.003449717,0.001363233,0.001187674,0.002946063,0.0002588693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001147101,"about_ca_system_score_gemma":0.000212618,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001435034,"about_ca_topic_score_gemma":0.0009479892,"domain_scores_codex":[0.9912045,0.0007051848,0.001955634,0.00149065,0.002459046,0.002185013],"domain_scores_gemma":[0.9922523,0.0009820381,0.001209922,0.003040766,0.0006610316,0.001853905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001382562,0.001734433,0.6746047,0.0001757824,0.0009633102,0.0002119392,0.0008408797,0.00001740066,0.2534937,0.000004884069,0.02575411,0.04081637],"study_design_scores_gemma":[0.01854272,0.0003989261,0.9605207,0.001235129,0.000254847,0.000113683,0.0002728128,0.001695931,0.01134195,0.00008235325,0.004650054,0.0008909056],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886744,0.0009869174,0.0001907057,0.004559344,0.001281315,0.001913269,0.0003864728,0.0003495008,0.001658058],"genre_scores_gemma":[0.9901024,0.004333603,0.002921282,0.0003615084,0.0007645437,0.0001661608,0.0001378656,0.0001959552,0.001016675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.285916,"threshold_uncertainty_score":0.9995244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974775914","doi":"10.1177/135245850000600210","title":"Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Biopsychosocial model; CIDI; Depression (economics); Medicine; Population; Psychiatry; Clinical psychology; National Comorbidity Survey; Comorbidity; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.07727314593194598,"gpt":0.2984862110091326,"spread":0.2212130650771867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001128981,0.0004872756,0.001085679,0.0007415969,0.000549531,0.0001087825,0.0003880989,0.0003700876,0.0018455],"category_scores_gemma":[0.001640347,0.0004211591,0.0005170318,0.001013236,0.0002913697,0.0004923267,0.0001299607,0.001132261,0.0001407936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000391452,"about_ca_system_score_gemma":0.0001143893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001157325,"about_ca_topic_score_gemma":0.0004035587,"domain_scores_codex":[0.9950494,0.0003709198,0.001548238,0.0006415996,0.001391511,0.0009983899],"domain_scores_gemma":[0.9974614,0.0006096851,0.0004743601,0.0005275417,0.0003849393,0.0005421117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001884482,0.000820238,0.8113288,0.00006962929,0.0001461553,0.00001275207,0.0006787418,0.0002757925,0.09275159,8.825135e-7,0.0007529114,0.09127808],"study_design_scores_gemma":[0.0126649,0.0002935076,0.9724364,0.002188992,0.00008819228,0.00005347782,0.0002518817,0.005457055,0.005918202,0.00002731343,0.0002560886,0.0003640238],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961249,0.001299831,0.00006803422,0.0005437216,0.0003453215,0.000954162,0.0000719991,0.00009059985,0.0005014014],"genre_scores_gemma":[0.9916215,0.003944068,0.003428813,0.00008961917,0.0004566177,0.00007598093,0.00005389281,0.00009063898,0.0002388549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1611076,"threshold_uncertainty_score":0.999824,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129757393","doi":"10.1191/1352458505ms1192oa","title":"Regional variation of multiple sclerosis prevalence in Canada","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Demography; Logistic regression; Confounding; Odds ratio; Medicine; Odds; Multiple sclerosis; Epidemiology; Prevalence; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1174418285751787,"gpt":0.2834842559907382,"spread":0.1660424274155595,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001166578,0.0003848615,0.0008003358,0.0004859143,0.0002887982,0.00005543591,0.0004392735,0.0001396626,0.0004673105],"category_scores_gemma":[0.0024075,0.0003470196,0.0002638,0.000702692,0.0001861694,0.000482344,0.0001735299,0.000933318,0.00002401876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002340819,"about_ca_system_score_gemma":0.001964279,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2689569,"about_ca_topic_score_gemma":0.6180489,"domain_scores_codex":[0.9950544,0.0002791522,0.00137179,0.0005262927,0.001842399,0.0009259198],"domain_scores_gemma":[0.9968257,0.0008444753,0.0005464348,0.000523265,0.0007283095,0.0005318151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006809217,0.0005414612,0.7959683,0.0002162535,0.0001736528,0.00001339186,0.0009034097,0.002447898,0.1569232,0.000006842383,0.004882,0.03724262],"study_design_scores_gemma":[0.007017995,0.0001483965,0.9653389,0.001418318,0.00005479236,0.00007029039,0.0003727109,0.01651759,0.007559769,0.000006230743,0.00120403,0.0002910118],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993375,0.00152775,0.0003342052,0.003440307,0.0002685289,0.0007127331,0.00008143974,0.00003255986,0.0002274851],"genre_scores_gemma":[0.9851646,0.005605344,0.00800868,0.0004203015,0.0005450531,0.00006100139,0.00001277834,0.00005255969,0.0001296353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.349092,"threshold_uncertainty_score":0.9998982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135746117","doi":"10.1177/1352458509357065","title":"Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results","year":2009,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Neurological Institute and Hospital; St. Michael's Hospital","funders":"","keywords":"Fingolimod; Medicine; Adverse effect; Multiple sclerosis; Placebo; Internal medicine; Clinical trial; Surgery; Pathology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.07880616782050656,"gpt":0.2823788777459828,"spread":0.2035727099254762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00114538,0.0003274832,0.0005148718,0.0002632599,0.0003557557,0.00008141847,0.0005022933,0.0002033814,0.00001718544],"category_scores_gemma":[0.0008229775,0.0003075299,0.0002228462,0.0003479491,0.00006490527,0.00003194368,0.0001473852,0.000412118,0.00000431119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003334504,"about_ca_system_score_gemma":0.00008770225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001634249,"about_ca_topic_score_gemma":0.0002074228,"domain_scores_codex":[0.9971682,0.0002373097,0.001049921,0.000527624,0.0004355993,0.0005813649],"domain_scores_gemma":[0.9985546,0.0000416228,0.0004320332,0.0005146242,0.0002210031,0.0002361417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002414502,0.005458047,0.0111805,0.000005985406,0.00007578712,0.000007764392,0.001617103,0.001793217,0.9562445,0.000003320917,0.0008835447,0.02031568],"study_design_scores_gemma":[0.1443045,0.01638971,0.3174514,0.000501149,0.0001690655,0.00005104102,0.004915702,0.00319905,0.5083389,0.00005314124,0.003408718,0.001217564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982035,0.0005799749,0.0002140644,0.0001144476,0.0003446616,0.0003812911,0.00005675649,0.00001830266,0.00008696315],"genre_scores_gemma":[0.9970721,0.0003785333,0.001746901,0.000180611,0.0004951349,0.00001261061,0.00003555133,0.00003490747,0.00004367442],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4479057,"threshold_uncertainty_score":0.9999377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112063945","doi":"10.1177/1352458514564485","title":"A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; EMD Serono; National Institutes of Health; Multiple Sclerosis Society of Canada; Cleveland Clinic Foundation; Ironwood Pharmaceuticals, Incorporated; National Multiple Sclerosis Society; Genentech; Novartis Pharmaceuticals Corporation; National Heart, Lung, and Blood Institute; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Cleveland Clinic; Teva Pharmaceutical Industries; Bayer HealthCare; Eli Lilly and Company; U.S. Department of Defense; Sanofi; Biogen; Pfizer; MedDay Pharmaceuticals; GlaxoSmithKline; Gilead Sciences","keywords":"Multiple sclerosis; Medicine; Peripheral; Incidence (geometry); Disease; Vascular disease; Cardiology; Stroke (engine); Internal medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.08095027036917916,"gpt":0.3097029784924795,"spread":0.2287527081233003,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005042234,0.0009118222,0.007197817,0.0004439846,0.0003208564,0.00008788156,0.0008494497,0.0002946278,0.00004359771],"category_scores_gemma":[0.01671042,0.0005594633,0.002466761,0.0008391803,0.0009599582,0.0002399726,0.000930021,0.001399778,0.000003002349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003798621,"about_ca_system_score_gemma":0.0005764481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001685474,"about_ca_topic_score_gemma":0.00003156114,"domain_scores_codex":[0.9900885,0.002911732,0.00327411,0.0008788324,0.002094734,0.0007520674],"domain_scores_gemma":[0.9930077,0.001795007,0.002183188,0.001670431,0.0006640407,0.0006796824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00002867123,0.0001614081,0.04097229,0.9296986,0.001099051,0.000002436934,0.0001810674,0.000003054075,0.00006313559,0.000001613149,0.00007532818,0.02771329],"study_design_scores_gemma":[0.00133038,0.0001020003,0.1474215,0.842714,0.006083421,0.00004215738,0.00004084483,0.0002898379,0.000007492588,0.000001723488,0.001565479,0.0004012038],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005038962,0.9881886,0.00002686163,0.00008897403,0.0001887881,0.006252284,0.0001895811,0.00001811801,0.000007850167],"genre_scores_gemma":[0.01915859,0.9794173,0.0005023923,0.00007661425,0.0001332879,0.0005610791,0.000009492259,0.0001065027,0.00003469307],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1064492,"threshold_uncertainty_score":0.9996857,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2578514106","doi":"10.1177/1352458516688955","title":"Processing speed test: Validation of a self-administered, iPad <sup>®</sup> -based tool for screening cognitive dysfunction in a clinic setting","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Genentech; Cleveland Clinic; Biogen; Novartis Pharma; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Cognition; Psychology; Test (biology); Natalizumab; Audiology; Reliability (semiconductor); Technician; Medicine; Physical medicine and rehabilitation; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.1529665399238752,"gpt":0.3671240710117765,"spread":0.2141575310879013,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003329288,0.0003668963,0.0008169726,0.0005260787,0.001337966,0.0004135035,0.0003236741,0.0002022343,0.00006724035],"category_scores_gemma":[0.02209189,0.0003319546,0.000380596,0.0002464834,0.0002510542,0.0007565103,0.0001502826,0.000771741,0.00001073868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002618481,"about_ca_system_score_gemma":0.0004642091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004284765,"about_ca_topic_score_gemma":0.00002022185,"domain_scores_codex":[0.996209,0.0002168863,0.001319771,0.0005489172,0.0009397956,0.0007656033],"domain_scores_gemma":[0.9943998,0.00211524,0.001392171,0.000428709,0.00140529,0.0002588331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002469098,0.0008793466,0.857192,0.0006422982,0.0001942008,0.00001375784,0.001616216,0.0004319916,0.03162519,2.448888e-7,0.0002089326,0.1047267],"study_design_scores_gemma":[0.02432975,0.001075571,0.7575397,0.005814427,0.0002326232,0.00002871621,0.001843105,0.1794362,0.02930266,0.000007069204,0.0000763721,0.000313701],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865274,0.0001327559,0.009948356,0.001118512,0.0001090105,0.001835205,0.00009785344,0.00007084344,0.0001600433],"genre_scores_gemma":[0.9703192,0.0001085333,0.02862339,0.0001263989,0.0005226518,0.0001154922,0.00004529758,0.00007036793,0.00006873238],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1790042,"threshold_uncertainty_score":0.9999622,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026497829","doi":"10.1177/1352458512470310","title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Medicine; Antibody; Multiple sclerosis; Aquaporin 4; Immunology; Immunoglobulin G; Pathology; Experimental autoimmune encephalomyelitis","retraction":null,"screen_n_in":null,"score":{"opus":0.09708425003817218,"gpt":0.3268405672589309,"spread":0.2297563172207587,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00188088,0.0006455441,0.001135812,0.001045999,0.0007834615,0.0002172256,0.0004192913,0.0002271087,0.0003371305],"category_scores_gemma":[0.006108589,0.0005520256,0.000494989,0.001119513,0.0003102605,0.0009521872,0.0004083166,0.001880436,0.0002474897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005343705,"about_ca_system_score_gemma":0.0002267417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003339965,"about_ca_topic_score_gemma":0.00005555661,"domain_scores_codex":[0.9939879,0.0004668239,0.001290245,0.0006330917,0.001491557,0.002130398],"domain_scores_gemma":[0.996414,0.0009542978,0.000468042,0.0005284272,0.0005455154,0.001089712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000513168,0.0006340425,0.8928673,0.0002105941,0.0001713621,0.0001264321,0.003672936,0.00009243578,0.09205207,0.00001417693,0.000509463,0.00913605],"study_design_scores_gemma":[0.006131493,0.000344196,0.9782099,0.0006229755,0.0001302611,0.0003617537,0.001691713,0.001713284,0.009723601,0.000008468047,0.0005321069,0.0005302447],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914907,0.003654795,0.0003622262,0.0009844325,0.0007240254,0.0009673537,0.00004295455,0.0001190983,0.001654398],"genre_scores_gemma":[0.9751405,0.009980682,0.01111963,0.0001667355,0.003223857,0.00006374709,0.0000197654,0.0001074239,0.000177726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08534264,"threshold_uncertainty_score":0.9996931,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2395316927","doi":"10.1177/1352458516649037","title":"Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; NeuroRx Research (Canada)","funders":"National Institute for Health and Care Research; Biogen","keywords":"Glatiramer acetate; Dimethyl fumarate; Medicine; Adverse effect; Multiple sclerosis; Relapsing remitting; Randomized controlled trial; Interim analysis; Placebo; Discontinuation; Internal medicine; Magnetic resonance imaging; Psychiatry; Radiology; Pathology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05278964814425009,"gpt":0.2852498998176108,"spread":0.2324602516733608,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001378075,0.0004277796,0.002372826,0.001606048,0.0001310876,0.00003124359,0.0002771259,0.0002022065,0.0001856262],"category_scores_gemma":[0.002860254,0.0002541039,0.001339899,0.001237478,0.0003542253,0.0002556852,0.0001470073,0.0004053103,0.00001375696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000157486,"about_ca_system_score_gemma":0.0001357802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006128121,"about_ca_topic_score_gemma":0.0003033808,"domain_scores_codex":[0.9955761,0.0008091331,0.001808491,0.0005037381,0.000751176,0.0005513703],"domain_scores_gemma":[0.9954646,0.001952987,0.001035203,0.000618201,0.0004131697,0.0005158318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05272872,0.004152324,0.494532,0.00008870211,0.004470373,0.0001311558,0.0006090967,0.0001450167,0.4284701,0.000001005987,0.00002950879,0.01464193],"study_design_scores_gemma":[0.2036392,0.0008262743,0.7407928,0.002800322,0.006059977,0.00001488539,0.0001299435,0.002122744,0.04337952,0.00000622808,6.721217e-7,0.0002274196],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925776,0.004345915,0.001116851,0.00005841144,0.0003520846,0.001444479,0.00005672669,0.00003602831,0.00001190535],"genre_scores_gemma":[0.9964525,0.002960856,0.000254028,0.00005452927,0.00007421479,0.00008055142,0.0000119073,0.00005141534,0.00006005623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3850906,"threshold_uncertainty_score":0.9999911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970963099","doi":"10.1177/135245850000600207","title":"Cost and health related quality of life consequences of multiple sclerosis","year":2000,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"London Health Sciences Centre; McMaster University; Nexus Clinical Research (Canada)","funders":"Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Health care; Physical therapy; Quality-adjusted life year; Expanded Disability Status Scale; Cost effectiveness; Psychiatry; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.3555741367552577,"gpt":0.3816800276124991,"spread":0.02610589085724146,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003962589,0.0004245837,0.001841493,0.0004029548,0.0005435903,0.00006494086,0.0003343686,0.000213998,0.001100201],"category_scores_gemma":[0.003842034,0.0003531504,0.0004259473,0.0006886469,0.001647095,0.0003178951,0.0001394243,0.000878231,0.00002321976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000229121,"about_ca_system_score_gemma":0.0006456407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003624542,"about_ca_topic_score_gemma":0.0004241168,"domain_scores_codex":[0.9937252,0.0007517656,0.002674484,0.0005517711,0.001397491,0.0008993329],"domain_scores_gemma":[0.9952847,0.001102816,0.001201536,0.0005722808,0.0007396706,0.001099029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001497627,0.0007335659,0.7089801,0.0004634639,0.0005665983,0.000004107876,0.001913306,0.0001268325,0.182206,0.000019274,0.00200074,0.1014884],"study_design_scores_gemma":[0.01081473,0.0006746812,0.9740805,0.001595277,0.0000551399,0.00005561806,0.001129668,0.0008027119,0.01017815,0.00003492636,0.0002946914,0.0002839259],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883233,0.005274378,0.00007164116,0.004421064,0.0001479426,0.001078243,0.0002086624,0.00006235034,0.0004124052],"genre_scores_gemma":[0.9721153,0.02290741,0.004269067,0.0003357187,0.0001177694,0.00003637192,0.00001959584,0.00005145976,0.0001472877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2651004,"threshold_uncertainty_score":0.9998921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100170145","doi":"10.1177/1352458508096680","title":"High frequency of adverse health behaviors in multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Medicine; Overweight; Population; Obesity; Logistic regression; Behavioral Risk Factor Surveillance System; Environmental health; Socioeconomic status; Public health; Gerontology; Demography; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1716744254204,"gpt":0.3176550510414554,"spread":0.1459806256210554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001625347,0.0006050816,0.001677142,0.001197732,0.0008529734,0.00002472447,0.0005475382,0.0002647881,0.0006526407],"category_scores_gemma":[0.002304488,0.0005400486,0.0006522149,0.001276098,0.0007940918,0.0005306687,0.0002643047,0.001581765,0.00007575305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001014529,"about_ca_system_score_gemma":0.0008169001,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00601282,"about_ca_topic_score_gemma":0.001830828,"domain_scores_codex":[0.9932019,0.0004788488,0.002182454,0.0007420317,0.001859719,0.001535105],"domain_scores_gemma":[0.9959688,0.0005481471,0.0008744442,0.0008227746,0.0007361578,0.001049703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003998805,0.001458555,0.8497431,0.0001259601,0.000152285,0.00009454766,0.001889141,0.0001974348,0.1341877,0.000007408057,0.001487918,0.01025612],"study_design_scores_gemma":[0.01328244,0.0006746455,0.9753023,0.001533334,0.00004701373,0.0002220462,0.0008485229,0.0003708228,0.007177876,0.0000118058,0.0001221219,0.000407094],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947373,0.001419262,0.0001966525,0.001542205,0.0005330397,0.001186737,0.0001485451,0.00009961602,0.0001366646],"genre_scores_gemma":[0.9720064,0.01014203,0.01677822,0.000341619,0.0003607132,0.0001011612,0.00003849553,0.0001082185,0.0001231401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1270098,"threshold_uncertainty_score":0.9997051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996975196","doi":"10.1191/1352458505ms1200cr","title":"Neuromyelitis optica with hypothalamic involvement","year":2005,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Neuromyelitis optica; Multiple sclerosis; Medicine; Pathology; Neuroscience; Immunology; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.2391815838733827,"gpt":0.3555429929514433,"spread":0.1163614090780606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009874628,0.001349546,0.004152672,0.0009832144,0.0007130873,0.0004265103,0.0007729289,0.000453705,0.0007061901],"category_scores_gemma":[0.0009385836,0.0008564378,0.001550576,0.0008392718,0.0004635646,0.0003058557,0.0004387093,0.003240628,0.0004688202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001246727,"about_ca_system_score_gemma":0.00116294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003065669,"about_ca_topic_score_gemma":0.00005261746,"domain_scores_codex":[0.992804,0.0005005313,0.001828595,0.001079038,0.002164094,0.001623755],"domain_scores_gemma":[0.9952603,0.0008116509,0.0009578873,0.001134133,0.0006369203,0.001199117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009397667,0.0004244302,0.0003172396,0.004944074,0.001431424,0.0002395628,0.000104552,0.000007893128,0.00004419505,0.000003655164,0.003502578,0.9888864],"study_design_scores_gemma":[0.003714357,0.0008105784,0.003835241,0.04530727,0.001770039,0.002045643,0.00007841297,0.0000907727,0.00000992351,0.000001474585,0.9415331,0.000803183],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002560753,0.9950075,0.0001101337,0.0004834202,0.0003841452,0.002371503,0.0001299635,0.0001550675,0.001102222],"genre_scores_gemma":[0.0004717787,0.9870762,0.007847025,0.0002086274,0.00278281,0.0003769444,0.0001010022,0.0003295178,0.0008060834],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9880832,"threshold_uncertainty_score":0.9999256,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2320749905","doi":"10.1177/1352458516638941","title":"The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Genentech; F. Hoffmann-La Roche; Sanofi","keywords":"Multiple sclerosis; Medicine; Clinical neurology; Clinical endpoint; Physical medicine and rehabilitation; Expanded Disability Status Scale; Physical therapy; Pediatrics; Psychology; Internal medicine; Neuroscience; Clinical trial; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.1077084951002788,"gpt":0.3424609425528899,"spread":0.2347524474526111,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003931257,0.0007376725,0.001099075,0.000258223,0.001914032,0.0004494038,0.000888532,0.0003398681,0.0002059418],"category_scores_gemma":[0.008359969,0.0003886552,0.0006807664,0.0005046615,0.00154359,0.001030038,0.0005047283,0.001213493,0.00002408679],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001543771,"about_ca_system_score_gemma":0.000598993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001068239,"about_ca_topic_score_gemma":0.001180311,"domain_scores_codex":[0.9930744,0.0006842511,0.00169758,0.001173961,0.001317143,0.002052621],"domain_scores_gemma":[0.9927205,0.003136741,0.000728306,0.001285345,0.001044766,0.001084314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00505318,0.001045841,0.1859689,0.0001229237,0.0001824455,0.000009367731,0.0005389323,0.000003918944,0.2341591,0.000008225185,0.001164898,0.5717423],"study_design_scores_gemma":[0.0247714,0.001683706,0.9294865,0.001932054,0.00007745431,0.00005160897,0.001133462,0.005507064,0.03017903,0.0001018417,0.004477372,0.0005984796],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788836,0.002260264,0.001884585,0.00962396,0.0008657922,0.005840669,0.0003606566,0.0002064641,0.00007406957],"genre_scores_gemma":[0.9846562,0.002448692,0.009266717,0.0001928565,0.001182227,0.001895613,0.00003849072,0.0001459516,0.0001732311],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7435176,"threshold_uncertainty_score":0.999993,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131078277","doi":"10.1177/1352458512436594","title":"Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University of Ottawa; Research Canada; McGill University; University of British Columbia","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo; Sanofi","keywords":"Teriflunomide; Medicine; Adverse effect; Discontinuation; Internal medicine; Placebo; Multiple sclerosis; Asymptomatic; Population; Interim analysis; Gastroenterology; Surgery; Randomized controlled trial; Fingolimod; Immunology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1454125951690546,"gpt":0.3555126556853214,"spread":0.2101000605162668,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003335901,0.0005438117,0.00165112,0.001104262,0.0003088361,0.00008910134,0.0004329232,0.0002063723,0.00005577246],"category_scores_gemma":[0.00554838,0.0004904667,0.0003281692,0.001020443,0.0003096442,0.0005918388,0.0005638269,0.0009733513,0.00001489837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003849687,"about_ca_system_score_gemma":0.0001416333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006473765,"about_ca_topic_score_gemma":0.0007756597,"domain_scores_codex":[0.9937239,0.0005897628,0.002350939,0.000674197,0.001366214,0.001295016],"domain_scores_gemma":[0.9959737,0.0009267021,0.0007669707,0.0007974507,0.0005002511,0.001034929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0200363,0.004327067,0.6834671,0.0001119521,0.0003836725,0.00002058267,0.01950421,0.00007731234,0.2036192,6.165594e-7,0.0003273294,0.06812464],"study_design_scores_gemma":[0.09843224,0.002445353,0.8856362,0.002439135,0.0001936293,0.00003783257,0.003586367,0.0003072371,0.006452971,5.0074e-7,0.0001040633,0.0003644863],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955442,0.0009110671,0.0001439444,0.0002350343,0.0007432878,0.002193748,0.0001408928,0.00004519465,0.00004265344],"genre_scores_gemma":[0.9961725,0.001270359,0.001977115,0.00006045384,0.0002594111,0.00005354371,0.00001984136,0.00009671017,0.00009008343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2021691,"threshold_uncertainty_score":0.9997547,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167461562","doi":"10.1177/1352458511432328","title":"Obstructive sleep apnea is associated with fatigue in multiple sclerosis","year":2011,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Epworth Sleepiness Scale; Medicine; Obstructive sleep apnea; Polysomnography; Physical therapy; Expanded Disability Status Scale; Excessive daytime sleepiness; Multiple sclerosis; Body mass index; Depression (economics); Multiple Sleep Latency Test; Internal medicine; Sleep disorder; Apnea; Insomnia; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.2158556522993224,"gpt":0.292958377297438,"spread":0.07710272499811563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001343685,0.0008193633,0.00142998,0.0009803721,0.0008402783,0.0001861988,0.0006399027,0.0003987314,0.0009736416],"category_scores_gemma":[0.003825105,0.0006499254,0.0004853473,0.001530861,0.0007352166,0.0007902926,0.0003139991,0.002039476,0.0001027507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000955436,"about_ca_system_score_gemma":0.00023955,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008717115,"about_ca_topic_score_gemma":0.001438176,"domain_scores_codex":[0.9935489,0.0004614076,0.001343919,0.001009706,0.001821211,0.001814851],"domain_scores_gemma":[0.9955609,0.0007989174,0.0006784126,0.000802234,0.00115947,0.001000021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001914439,0.001503159,0.9257047,0.00005366914,0.00103322,0.0001591269,0.008810804,0.00006296005,0.03089724,0.000006350016,0.001300929,0.02855343],"study_design_scores_gemma":[0.01618647,0.0008585413,0.9553974,0.001579628,0.0001703434,0.0001059608,0.002508814,0.005745835,0.01658847,0.00003799374,0.0001242736,0.0006963057],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994036,0.0005098425,0.0009367028,0.000572145,0.0003698037,0.001309781,0.0001393199,0.0001837698,0.001942628],"genre_scores_gemma":[0.9898872,0.0008003903,0.007941867,0.0005132037,0.0002851439,0.0001960993,0.00003261943,0.0001678251,0.0001756535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02969269,"threshold_uncertainty_score":0.9999396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095210906","doi":"10.1177/1352458513500551","title":"Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital","funders":"Acorda Therapeutics; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Fingolimod; Lymphocyte; Medicine; Discontinuation; Multiple sclerosis; Placebo; Internal medicine; Immunology; Peripheral blood lymphocyte; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03061297707406864,"gpt":0.2156569809026939,"spread":0.1850440038286253,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009279592,0.00007508765,0.00008566264,0.00003817275,0.0001170262,0.00003834358,0.00004704155,0.00004778735,0.00005905086],"category_scores_gemma":[0.00002835337,0.00005084358,0.00002397488,0.00006326362,0.00005784615,0.00001204537,0.00001146151,0.00007221207,0.000004796222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005785651,"about_ca_system_score_gemma":0.00007103924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004991963,"about_ca_topic_score_gemma":0.00001044418,"domain_scores_codex":[0.9995703,0.00002742558,0.0001138537,0.0000958625,0.00008918423,0.0001034001],"domain_scores_gemma":[0.9996272,0.00001447595,0.0000937287,0.00009298493,0.000114666,0.00005695613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001170135,0.00007296572,0.7193421,0.000008443011,0.00007342236,4.156963e-7,0.0001300095,0.0001477023,0.2742966,0.00002414158,0.0007109634,0.005076293],"study_design_scores_gemma":[0.00402073,0.0005326182,0.9034794,0.00009371608,0.00002618852,0.0001307218,0.0001348055,0.000406333,0.08504873,0.00003382317,0.005863388,0.0002295417],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975054,0.0006777975,0.001291213,0.00002793806,0.00004609981,0.0001054151,0.000005041883,0.000005019112,0.00033611],"genre_scores_gemma":[0.9968321,0.0003007258,0.002543062,0.00004490081,0.0001371954,0.00001324,0.0000088244,0.00001290026,0.0001070425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1892478,"threshold_uncertainty_score":0.2073341,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163982375","doi":"10.1177/1352458514564486","title":"A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Biogen; Canadian Institutes of Health Research; IC Design Education Center; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Incidence (geometry); Medicine; Seizure Disorders; Epilepsy; Sleep (system call); Pediatrics; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.07869031043790795,"gpt":0.3200282810729547,"spread":0.2413379706350468,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003979645,0.0009203212,0.006044341,0.0006144308,0.0003496847,0.00006787494,0.0009557901,0.0003897899,0.00003617588],"category_scores_gemma":[0.01714292,0.0005638785,0.001191011,0.001171031,0.001170727,0.0002514035,0.0009065197,0.001689278,0.000003897271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002561974,"about_ca_system_score_gemma":0.0003147984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002113474,"about_ca_topic_score_gemma":0.0006602603,"domain_scores_codex":[0.9913231,0.001962741,0.003468709,0.0008275768,0.001632306,0.0007855336],"domain_scores_gemma":[0.9917792,0.003231949,0.002922466,0.00123645,0.0004300463,0.0003998763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00003162299,0.0001947412,0.02476297,0.8592708,0.0004712483,8.512108e-7,0.0002820277,0.000002418872,0.00005507447,0.000002130362,0.00009655993,0.1148296],"study_design_scores_gemma":[0.001984614,0.000213946,0.06706676,0.9251955,0.002759573,0.00008761715,0.0001203726,0.000409353,0.000006943234,0.000008790552,0.001699221,0.0004473767],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002621266,0.9902385,0.00005184012,0.0003327783,0.0001616255,0.006403926,0.000136712,0.00002027949,0.00003306241],"genre_scores_gemma":[0.04856744,0.9502029,0.0004581089,0.00008321147,0.00007139612,0.0004674699,0.000006677265,0.0001025245,0.00004023718],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1143822,"threshold_uncertainty_score":0.9996813,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2139655506","doi":"10.1177/1352458507077175","title":"Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors","year":2007,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McGill University; Jewish General Hospital; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society","keywords":"Psychosocial; Biopsychosocial model; Medicine; Physical therapy; Depression (economics); Psychology; Clinical psychology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.1430040843000215,"gpt":0.3120863215242343,"spread":0.1690822372242128,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002258447,0.0005667316,0.0008551297,0.0007348423,0.0008426335,0.0002593554,0.0002570634,0.0003376926,0.0001235657],"category_scores_gemma":[0.002571271,0.000449735,0.0002977105,0.0008288966,0.0003112495,0.0006104126,0.0001395439,0.001688051,0.00001742823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001323367,"about_ca_system_score_gemma":0.0001921345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005785413,"about_ca_topic_score_gemma":0.002313298,"domain_scores_codex":[0.9946072,0.0002510861,0.00116972,0.0006872292,0.001823,0.001461786],"domain_scores_gemma":[0.996364,0.0009311452,0.0005917446,0.0003550608,0.0005359375,0.001222088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00135553,0.0006259502,0.9747254,0.00004557329,0.0002746673,0.00006252491,0.002091844,0.00004306828,0.01201504,0.000004574988,0.0006948542,0.008060978],"study_design_scores_gemma":[0.01367224,0.0003637598,0.9798195,0.001127753,0.0001702994,0.00002763137,0.002165457,0.0005702588,0.001452119,0.00001580376,0.000138913,0.0004762329],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954453,0.0008781287,0.0002645326,0.001597747,0.0004409844,0.001023114,0.00007239636,0.0001165836,0.0001612859],"genre_scores_gemma":[0.9961374,0.001602922,0.001448329,0.00013423,0.0003324761,0.00004723461,0.00004362503,0.00009910274,0.0001547181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01231671,"threshold_uncertainty_score":0.9997954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090193300","doi":"10.1177/1352458512437814","title":"Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; University of British Columbia; University of Calgary; McGill University; University of Manitoba; Alberta Health; University of Alberta","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society","keywords":"Hyperlipidemia; Medicine; Diabetes mellitus; Comorbidity; Internal medicine; Population; Cohort; Pediatrics; Endocrinology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.33710085680591,"gpt":0.3325399533896033,"spread":0.004560903416306605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002087354,0.0003226723,0.000942435,0.0004613194,0.0003593077,0.00003946772,0.0001767998,0.0001741865,0.00004159727],"category_scores_gemma":[0.006486008,0.000281833,0.0003146752,0.000367497,0.0005458942,0.0005928054,0.0001280774,0.0004708812,0.000002212757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001505521,"about_ca_system_score_gemma":0.0001498327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000065603,"about_ca_topic_score_gemma":0.0000282383,"domain_scores_codex":[0.9966589,0.0003384333,0.001198006,0.0003346789,0.0007259771,0.0007440218],"domain_scores_gemma":[0.9956496,0.002152636,0.0005804158,0.0003488966,0.0008954623,0.0003729938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002237482,0.0006285778,0.7211385,0.0008261908,0.000200605,5.445007e-7,0.001103461,0.00006040772,0.2727439,0.00001910183,0.0003437753,0.002711265],"study_design_scores_gemma":[0.005765213,0.0004265964,0.8664067,0.002719286,0.0002391304,0.00001657259,0.001300912,0.001711811,0.1210638,0.00004004245,0.00008772685,0.000222173],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927938,0.004806814,0.0005326087,0.0003082364,0.0002087626,0.0010222,0.0002668192,0.00002384686,0.00003688537],"genre_scores_gemma":[0.9766917,0.008520495,0.01424356,0.00007190539,0.000240233,0.000146433,0.00003060336,0.00004613085,0.000008884197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1516801,"threshold_uncertainty_score":0.9999634,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072924355","doi":"10.1177/1352458514546790","title":"Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Natalizumab; Pregnancy; Medicine; Obstetrics; Miscarriage; Fetus; Premature birth; Prospective cohort study; Multiple sclerosis; Gynecology; Gestation; Internal medicine; Immunology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.09738529578808428,"gpt":0.3143172657045213,"spread":0.216931969916437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007590002,0.0002963633,0.0008810821,0.0002731196,0.0002806684,0.00009784667,0.0001595013,0.0001221617,0.00005822673],"category_scores_gemma":[0.002876241,0.0002217006,0.0002735014,0.000260611,0.00006517049,0.0004835828,0.00006093409,0.0005651562,0.000007194328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001776037,"about_ca_system_score_gemma":0.0001959478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002943824,"about_ca_topic_score_gemma":0.00008489723,"domain_scores_codex":[0.9973463,0.0002554384,0.0008376669,0.0003856696,0.0007368937,0.0004379742],"domain_scores_gemma":[0.9984942,0.0003873416,0.0003172397,0.000307275,0.0001533583,0.0003405847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003647699,0.0009888335,0.9776072,0.00003956587,0.0002916252,0.00005223442,0.001658933,0.000009486128,0.0008555895,0.00003475586,0.00002518424,0.01807186],"study_design_scores_gemma":[0.06402582,0.0007721983,0.928541,0.004721649,0.0001731928,0.00007697485,0.0005008381,0.0007541683,0.00008682854,0.0001174022,0.00002712733,0.0002027765],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917662,0.003930451,0.0006849659,0.0006435514,0.0004331258,0.002044717,0.000006654281,0.0000601723,0.0004302211],"genre_scores_gemma":[0.9976599,0.0001701283,0.001164483,0.0001753113,0.00009571715,0.000268972,0.000008368615,0.00003437298,0.0004227196],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06366105,"threshold_uncertainty_score":0.9040687,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}